Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Hepatitis

  Free Subscription


07.10.2019

1 AIDS
5 Clin Infect Dis
2 Dig Dis Sci
2 Eur J Gastroenterol Hepatol
1 Int J STD AIDS
4 J Hepatol
1 J Immunol
2 J Infect Dis
1 J Med Virol
4 J Viral Hepat
1 MMWR Morb Mortal Wkly Rep
1 Nature
3 PLoS One
1 Transplantation
1 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. MARTINEZ-REBOLLAR M, Pascual PP, de la Mora L, Londono MC, et al
    Contributing awareness of autoimmune hepatitis in HIV patients.
    AIDS. 2019;33:2103-2105.
    PubMed     Text format    


    Clin Infect Dis

  2. PIROTH L, Launay O, Miailhes P, Carrat F, et al
    Isolated anti-HBc serological profile: has the time come to vaccinate?
    Clin Infect Dis. 2017 Sep 15. doi: 10.1093.
    PubMed     Text format    

  3. INGILIZ P, Wehmeyer MH, Boesecke C, Schulze Zur Wiesch J, et al
    Reinfection with the hepatitis C virus in men who have sex with men after successful treatment with direct-acting antivirals in Germany: Current incidence rates compared with rates during the interferon era.
    Clin Infect Dis. 2019 Sep 28. pii: 5575902. doi: 10.1093.
    PubMed     Text format     Abstract available

  4. CHROMY D, Schmidt R, Mandorfer M, Lang GF, et al
    HCV-RNA is commonly detectable in rectal and nasal fluids of patients with high viremia.
    Clin Infect Dis. 2019 Sep 28. pii: 5575905. doi: 10.1093.
    PubMed     Text format     Abstract available

  5. FALADE-NWULIA O
    HCV Elimination requires more than Good Drugs.
    Clin Infect Dis. 2019 Sep 29. pii: 5575956. doi: 10.1093.
    PubMed     Text format    

  6. TSERTSVADZE T, Gamkrelidze A, Chkhartishvili N, Abutidze A, et al
    Three years of progress towards achieving hepatitis C elimination in the country of Georgia, April 2015 - March 2018.
    Clin Infect Dis. 2019 Sep 29. pii: 5575959. doi: 10.1093.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  7. O'BEIRNE J
    Readmission Following Hospitalization for Alcoholic Hepatitis: Costly or Cost-Effective?
    Dig Dis Sci. 2019 Sep 30. pii: 10.1007/s10620-019-05854.
    PubMed     Text format    

  8. WU SF, Tseng CW, Ho YC, Chen YC, et al
    Regulatory T Cell Function Modulated After Successful Direct-Acting Antiviral Treatment for Chronic Hepatitis C Patients.
    Dig Dis Sci. 2019 Sep 26. pii: 10.1007/s10620-019-05850.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  9. ABBAS OM, Khalifa KAE, Makhlouf MM, Osman NF, et al
    Influence of esophageal variceal bleeding on iron status in chronic hepatitis C patients.
    Eur J Gastroenterol Hepatol. 2019 Sep 16. doi: 10.1097/MEG.0000000000001547.
    PubMed     Text format     Abstract available

  10. SLIEM HA, Salem AS, Hussien WM, El Sayed HRA, et al
    Arterial wall structural changes in noncirrhotic chronic hepatitis C patients.
    Eur J Gastroenterol Hepatol. 2019;31:1432-1438.
    PubMed     Text format     Abstract available


    Int J STD AIDS

  11. CHKHARTISHVILI N, Bolokadze N, Rukhadze N, Dvali N, et al
    Impact of hepatitis C virus antibody positivity on mortality and causes of death in people living with HIV in Georgia.
    Int J STD AIDS. 2019 Sep 27:956462419866055. doi: 10.1177/0956462419866055.
    PubMed     Text format    


    J Hepatol

  12. LIU LZ, Sun J
    Early initiation of antiviral therapy contributes to a rapid and significant loss of serum HBsAg in infantile-onset hepatitis B.
    J Hepatol. 2019 Sep 24. pii: S0168-8278(19)30464.
    PubMed     Text format    

  13. ZHAO P
    Reply to: "Antiviral treatment for hepatitis B in infancy: Still an issue for debate" and "Early initiation of antiviral therapy contributes to a rapid and significant loss of serum HBsAg in infantile-onset hepatitis B".
    J Hepatol. 2019 Sep 26. pii: S0168-8278(19)30525.
    PubMed     Text format    

  14. BLACKARD JT, Kwara A, Sherman KE
    In response to identification of a quadruple mutation that confers tenofovir resistance in chronic hepatitis B patients.
    J Hepatol. 2019 Sep 26. pii: S0168-8278(19)30418.
    PubMed     Text format    

  15. BELLI LS, Perricone G, Adam R, Cortesi PA, et al
    Impact of DAAs on liver transplantation: major effects on the evolution of indications and results. An ELITA study based on the ELTR registry.
    J Hepatol. 2018 Jun 22. pii: S0168-8278(18)32163.
    PubMed     Text format     Abstract available


    J Immunol

  16. SHI W, Shao T, Li JY, Fan DD, et al
    BTLA-HVEM Checkpoint Axis Regulates Hepatic Homeostasis and Inflammation in a ConA-Induced Hepatitis Model in Zebrafish.
    J Immunol. 2019 Sep 27. pii: jimmunol.1900458. doi: 10.4049/jimmunol.1900458.
    PubMed     Text format     Abstract available


    J Infect Dis

  17. ZOU B, Yeo YH, Le MH, Henry L, et al
    Prevalence of viremic HCV infection by age, race/ethnicity, birthplace and disease awareness among viremic persons in the U.S., 1999-2016.
    J Infect Dis. 2019 Sep 27. pii: 5575100. doi: 10.1093.
    PubMed     Text format     Abstract available

  18. SU TH, Peng CY, Tseng TC, Yang HC, et al
    Serum Mac-2-binding protein glycosylation isomer at virological remission predicts hepatocellular carcinoma and death in chronic hepatitis B related cirrhosis.
    J Infect Dis. 2019 Oct 1. pii: 5580041. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Med Virol

  19. SAMPEDRO A, Casanovas I, Ceballos J, Rodriguez-Granger J, et al
    Comparative evaluation of two immunoassays for serological diagnosis of hepatitis E.
    J Med Virol. 2019 Oct 3. doi: 10.1002/jmv.25601.
    PubMed     Text format     Abstract available


    J Viral Hepat

  20. PAPATHEODORIDI M, Hadziyannis E, Berby F, Zachou K, et al
    Predictors of HBsAg loss, relapse and retreatment after discontinuation of effective oral antiviral therapy in non-cirrhotic HBeAg-negative chronic hepatitis B.
    J Viral Hepat. 2019 Sep 28. doi: 10.1111/jvh.13211.
    PubMed     Text format     Abstract available

  21. PHILLIPS C, Schulkind J, O'Sullivan M, Edelman N, et al
    Improving access to care for People Who Inject Drugs: Qualitative evaluation of Project ITTREAT, an integrated community hepatitis C service.
    J Viral Hepat. 2019 Sep 30. doi: 10.1111/jvh.13214.
    PubMed     Text format     Abstract available

  22. SHEN K, Yang NS, Huang W, Fitzpatrick TS, et al
    A crowdsourced intervention to decrease hepatitis B stigma in men who have sex with men in China: a cohort study.
    J Viral Hepat. 2019 Sep 30. doi: 10.1111/jvh.13213.
    PubMed     Text format     Abstract available

  23. YANG R, Gui X, Ke H, Xiong Y, et al
    Long-term observation on Hepatitis B surface antigen (HBsAg) seroclearance in therapy experienced HIV/HBV co-infected Chinese.
    J Viral Hepat. 2019 Sep 30. doi: 10.1111/jvh.13212.
    PubMed     Text format     Abstract available


    MMWR Morb Mortal Wkly Rep

  24. KO JY, Haight SC, Schillie SF, Bohm MK, et al
    National Trends in Hepatitis C Infection by Opioid Use Disorder Status Among Pregnant Women at Delivery Hospitalization - United States, 2000-2015.
    MMWR Morb Mortal Wkly Rep. 2019;68:833-838.
    PubMed     Text format     Abstract available


    Nature

  25. ALFEI F, Kanev K, Hofmann M, Wu M, et al
    TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection.
    Nature. 2019;571:265-269.
    PubMed     Text format     Abstract available


    PLoS One

  26. O'CONNOR SM, Mixson-Hayden T, Ganova-Raeva L, Djibo DA, et al
    Integrated HIV surveillance finds recent adult hepatitis B virus (HBV) transmission and intermediate HBV prevalence among military in uncharacterized Caribbean country.
    PLoS One. 2019;14:e0222835.
    PubMed     Text format     Abstract available

  27. XI R, Kadur Lakshminarasimha Murthy P, Tung KL, Guy CD, et al
    SENP3-mediated host defense response contains HBV replication and restores protein synthesis.
    PLoS One. 2019;14:e0209179.
    PubMed     Text format     Abstract available

  28. SUMAYE R, Jansen F, Berkvens D, De Baets B, et al
    Rift Valley fever: An open-source transmission dynamics simulation model.
    PLoS One. 2019;14:e0209929.
    PubMed     Text format     Abstract available


    Transplantation

  29. BAE S, Durand CM, Garonzik-Wang JM, Chow EKH, et al
    Anti-Thymocyte Globulin versus Interleukin-2 Receptor Antagonist in Kidney Transplant Recipients with Hepatitis C Virus.
    Transplantation. 2019 Sep 13. doi: 10.1097/TP.0000000000002959.
    PubMed     Text format     Abstract available


    Vaccine

  30. OKENWA UJ, Dairo MD, Uba B, Ajumobi O, et al
    Maternal reasons for non-receipt of valid Hepatitis B birth dose among mother-infant pairs attending routine immunization clinics, South-east, Nigeria.
    Vaccine. 2019 Sep 24. pii: S0264-410X(19)31280.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: